Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: Lessons from a developing country
BackgroundCongenital Adrenal Hyperplasia (CAH) due to CYP11B1 is a rare autosomal recessive adrenal disorder that causes a decrease in cortisol production and accumulation of adrenal androgens and steroid precursors with mineralocorticoid activity. Clinical manifestations include cortisol deficiency...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2022-12-01
|
| シリーズ: | Frontiers in Endocrinology |
| 主題: | |
| オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fendo.2022.1015973/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
